16:51 - 29.07.2025

---

July 29, Fineko/abc.az. The income of British pharmaceutical company AstraZeneca in the 2nd quarter of 2025 amounted to $14.45 billion (12% higher than a year ago), ABC.AZ reports, referring to Bloomberg.

AstraZeneca's net profit grew by 27% up to $2.45 bn for Apr-Jun 2025. Earnings per share, excluding one-time factors, increased by 10% to $2.17.

AstraZeneca has confirmed its forecast for revenue growth in 2025 by 7-9%, excluding changes in exchange rates. Adjusted earnings per share are projected to increase by 10-13%.

AstraZeneca plans to invest $50 billion in the U.S. economy by 2030. The company expects that the investments will help it achieve its goal of increasing revenue up to $80 billion by 2030.